Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
NCT Number: NCT04504773
Anxiety is a common and impairing problem for children. The principle treatment for pediatric anxiety involves facing a child's fears in a stepwise approach through a therapeutic exercise called exposures. While exposures are effective, some feared situations cannot be confronted in a clinician's office (e.g., heights, public speaking, storms). This poses a logistical challenge in treatment that: (1) takes time away from patient care, (2) leads clinicians to rely on imagined exposures, and/or (3) requires families to complete exposures outside of the therapy visits. This creates a burden for clinicians and families, and impedes treatment success. Immersive virtual reality (VR) presents an innovative solution that allows children to face fears without leaving the clinician's office. While VR has been used to distract children during painful medical procedures, it has not been well examined as a primary treatment for pediatric anxiety. This study proposes to examine the effectiveness and acceptability of using immersive VR exposures to treat children and adolescents with specific phobias.
Looking for future studies?
Notify Me8 year–17 year
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21205, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive a single session of virtual reality exposure therapy that targets the participant's specific phobia stimuli.
Time frame: 1 week after virtual reality exposure therapy session
The ADIS-C/P CSR for the Specific Phobia is a single item rating that is made by a clinician. Scores are made on a 9-point scale that ranges from 0 (Not at all) to 8 (Very, very much). A score of 4 or greater considered to be indicative of a psychiatric disorder.
Time frame: 1 week after virtual reality exposure therapy session
Parent-reported rating of child anxiety that consists of 41-items. Items are rated on a 3-point scale that ranges from 0 (Not True) to 2 (Very True). The total score ranges from 0 to 82, with a total score of 25 or greater may indicate the presence of an anxiety disorder.
Johns Hopkins University
Other
Virtually Better: Using Immersive Virtual Reality to Treat Pediatric Anxiety
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02305537
Agoraphobia, Anxiety Disorders
Cambridge, Massachusetts, United States
View Trial DetailsNCT04111874
Anxiety Disorders, Autism Spectrum Disorder
Houston, Texas, United States
View Trial DetailsNCT03720795
Anxiety Disorders, Autism Spectrum Disorder
Houston, Texas, United States
View Trial DetailsNCT04909177
Phobia, Specific, Specific Phobia
Christchurch, Canterbury, New Zealand
View Trial Details